Hainan Free Trade Port deepens cooperation with Switzerland

July 08, 2024 12:36 AM AEST | By Cision

Hainan Free Trade Port deepens cooperation with Switzerland — Image source: Kalkine Media

Recent News

SAUNEX Partners with Saudi SIIVC in Strategic EV Initiative

China Matters' Feature: Exploring New Frontiers on Urban Governance

CCTV4: CMG VSCS Releases In-Depth Documentary: Navigation in the South...

All 8 Halls of the Main Venue of the 31st China (Guzhen) International...

HAIKOU, China, July 7, 2024 /PRNewswire/ -- A report from Hainan International Media Center (HIMC):

On July 4, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich, Switzerland.

From July 4-6, a delegation from China's southern Hainan Province held Hainan Free Trade Port (FTP) related promotion and exchange activities in Switzerland, cementing cooperation in the fields of medical health, education, and high-end shopping & consumption.

During their time in Switzerland, the Hainan delegation held discussions and research meetings with numerous important companies and institutions, including Merck, Richemont, Roche Diagnostics, EHL Hospitality Business School, Switzerland Global Enterprise, the World Trade Organization, and the World Intellectual Property Organization.

Inviting Swiss counterparts to leverage the FTP's preferential policies, Hainan is specifically promoting cooperation in the fields of medical health, independent school running, and intellectual property protection. Hainan also made a point of expressing their warm welcome to Swiss enterprises to take part in the 5th China International Consumer Products Expo in April, 2025.

Co-organized by Hainan's provincial government and the Switzerland Global Enterprise, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich on July 4. The event was well-received, with nearly 50 representatives from well-known Swiss companies and industry associations (including the Swiss Medical Technology Association, the the Swiss Scientific and Industrial Pharmaceutical Association, Novartis, Nestlé Health Science, Sonova, Similasan, Alcon, and IBSA) in attendance.

At the meeting, the Swiss side affirmed that the Hainan FTP's conducive business environment and preferential policies (especially the innovative measures in the Boao Lecheng International Medical Tourism Pilot Zone) mean that the island has broad development prospects in the medical and health industry. Lecheng has become the primary rapid access channel for global innovative medical products entering China, and many Swiss medical companies—in learning about how the FTP's preferential policies support Lecheng—are now planning to deepen cooperation with Hainan.

The conference saw contract signings take place between Sonova & the Boao Lecheng International Medical Tourism Pilot Zone, Industrie Biomediche Insubri SA & Susheng Biotech, and Dr. Dünner AG & Winhealth Pharma. Also, to promote innovative development in life sciences and the medical health industries, Switzerland Global Enterprise signed a memorandum of understanding with the Hainan Provincial Bureau of International Economic Development.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.